Centrus Energy (LEU) stock experienced a significant 24-hour surge of 5.21% on Wednesday, building upon its earlier pre-market gains. The nuclear fuel and services provider's stock price jump comes in the wake of its impressive second-quarter 2025 financial results and positive developments in its High-Assay Low-Enriched Uranium (HALEU) contracts.

The company's Q2 2025 performance significantly outpaced analyst expectations. Centrus reported adjusted earnings per share of $1.59, surpassing the consensus estimate of $0.82 by 93.43%. Revenue for the quarter reached $154.50 million, exceeding analyst projections of $125.49 million by 23.11%. Despite representing a year-over-year decrease, these figures demonstrate Centrus's resilience and ability to exceed market expectations in challenging conditions.

Adding to the positive sentiment, Centrus announced the successful completion of Phase 2 of its HALEU Operation Contract, delivering 900 kilograms of HALEU to the Department of Energy. Furthermore, the Department has exercised a portion of Phase 3 of the contract, valued at approximately $110 million, effective through June 30, 2026. This development not only signals continued confidence in Centrus's capabilities but also provides a strong foundation for future growth in the nuclear energy sector. The company's backlog, totaling $3.6 billion as of June 30, 2025, with a runway extending to 2040, further underscores its long-term potential in the evolving nuclear energy industry.